As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.
The Inlaks-Ravi Sankaran Internship for field biology, ecology and conservation is inviting applications from young applicants with bold and unconventional ideas for tackling conservation problems.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Sharing a government public notice on 'X', formerly Twitter, Sarma appealed to the people to send their suggestions on the proposed law to ban polygamy in Assam.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.
A bench of Justices MR Shah and BV Nagarathna said there cannot be any deviation from the educational qualifications mentioned in an advertisement of job.
The Supreme Court of India granted custody of a man suffering from cerebral palsy to his mother, a US national, after determining it was in his best interest due to his inability to make independent decisions. The court overruled a Madras High Court decision, finding the lower court's interaction with the son insufficient to assess his needs. The Supreme Court emphasized the son's limited cognitive capacity and the availability of specialized support in the US, where he had completed most of his schooling.
The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina.
The Drugs Controller General of India will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
The NTA had treated the two options as correct answers to the Physics question and had granted four marks to those examinees who had marked these options.
Under its new chairman Tuhin Kanta Pandey, the Securities and Exchange Board of India (Sebi) has gravitated towards greater transparency and ease of doing business, setting an objective of "effective and optimum" regulation. On Monday, during its first board meeting under Pandey, the regulator has decided to constitute a high-level committee (HLC) to review conflicts of interest and unveiled initiatives to simplify regulatory processes.
The Board decided to award full marks for it to students, following an outrage over the board allegedly promoting 'gender stereotyping' and supporting 'regressive notions'
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
BE's Corbevax is the first such vaccine in India to be approved as a heterologous COVID-19 booster in the country.
'It is imprudent on the part of Indian insurance companies to invest out of the shareholders' fund in a private limited company.'
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation has recommended the conduct of Phase III clinical trials of Russia's single dose COVID-19 vaccine Sputnik Light.
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.
'Understand your financial goals. Next, categorise them by size. Then evaluate your investment options.'
Can a culture survive as a way of life, even as the language and writing at its core, alter with time? Can we be rational and Malayalee or do we have to necessarily be religious and proudly cultural to be Malayalee? asks Shyam G Menon.
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.
Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.
FIFA's disciplinary committee will be asked to look into allegations of discrimination raised by the Palestinian Football Association (PFA) after it submitted a proposal to suspend Israel in May, world soccer's governing body said on Thursday.
Almost five years later, the three services have still not fully understood that joint/theatre commands are not a discussion point; they are the prime minister's diktat on a military reform measure that is in line with what armed forces around the world have implemented, points out Ajai Shukla.
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.
The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.
With the dissolution of former chief statistician Pronab Sen-led Standing Committee on Statistics (SCoS) by the Ministry of Statistics and Programme Implementation (MoSPI), the National Statistical Commission (NSC) has regained prominence as the primary statistical body to address issues regarding results, methodology and questionnaire, among others. A MoSPI official in an email informed the 16-member SCoS about the decision to dissolve it, citing that its work was "overlapping" with that of the Steering Committee for National Sample Surveys (NSS), which was set up in June this year.
An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.
The more people get vaccinated, the better it will be for the country and the economy, the National Conference vice president said.
Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.
Hours after Desai said that the draft is ready to be submitted to the state government, Chief Minister Pushkar Singh Dhami said the Uniform Civil Code will soon be implemented in Uttarakhand.
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
Ten Union ministers will be the permanent invitees to the Inter-State Council, according to an official notification.
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.
In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.
Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
The decision about the high-powered committee was taken as the government apparently thought of taking one step at a time instead of hurrying things up in the face of growing resistance from farmers who gave their lands for the development of Amaravati as the new capital, under the previous government headed by N Chandrababu Naidu, reports Dasarath Reddy.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances